title: Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH.
authors.forename: Manfredi
authors.initials: M
authors.lastname: Rizzo
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Montalto
authors.affiliation: The Institute of Hepatology The Foundation for Liver Research 69-75 Chenies Mews London, WC1E 6HX United Kingdom. m.vinciguerra@researchinliver.org.uk.
authors.forename: Manlio
authors.initials: M
authors.lastname: Vinciguerra
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects / Q000502:physiology*; D008055:Lipids / Q000037:antagonists & inhibitors / Q000097:blood*; D065626:Non-alcoholic Fatty Liver Disease / Q000097:blood* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D008055:Lipids